Home › Non-Muscle Invasive Bladder Cancer › New Jersey › Edison
Non-Muscle Invasive Bladder Cancer clinical trials in Edison, NJ
9 studies for Non-Muscle Invasive Bladder Cancer are looking for participants at sites in and around Edison (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer
RecruitingPhase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi away
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
RecruitingPhase 3
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi away
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
RecruitingPhase 2
- New Jersey Urology, LLC (Summit Health - Washington Township), Voorhees Township · 5 mi away
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
RecruitingPhase 3
- New Jersey Urology LLC, Voorhees Township · 5 mi away
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
RecruitingPhase 1
- MSK Basking Ridge, Basking Ridge · 15 mi away
Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy
RecruitingObservational study
- Rutgers Cancer Institute, New Brunswick · 3 mi away
A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)
RecruitingPhase 3
- Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge · 15 mi away
Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment
RecruitingPhase 1/2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi away
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
RecruitingPhase 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi away
- New Jersey Urology, LLC, Voorhees Township · 5 mi away
Non-Muscle Invasive Bladder Cancer trials in other cities
- Columbus, OH10 studies
- Dallas, TX10 studies
- New York City, NY10 studies
- Myrtle Beach, SC9 studies
- Baltimore, MD8 studies
- Syracuse, NY8 studies
- Nashville, TN8 studies
- Houston, TX7 studies
- Indianapolis, IN7 studies
- Birmingham, AL7 studies
- Philadelphia, PA7 studies
- Atlanta, GA7 studies
Other studies in Edison
- Breast Cancer68 studies
- Non-Small Cell Lung Cancer47 studies
- Cancer (all types)33 studies
- Prostate Cancer29 studies
- Colorectal Cancer23 studies
- Lung Cancer23 studies
- Multiple Myeloma22 studies
- Bladder Cancer21 studies
- Acute Myeloid Leukemia20 studies
- Ovarian Cancer20 studies
- Metastatic Cancer20 studies
- Endometrial Cancer19 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.